Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison

Area of Science:

• Immunology
• Oncology
• Inflammation Research

Background:

• Immune-Mediated Inflammatory Diseases (IMIDs) are associated with an increased risk of cancer.
• The precise mechanisms driving this association are not fully understood and remain debated.

Purpose of the Study:

• To review and synthesize current evidence on the relationship between IMIDs and cancer.
• To explore the underlying pathogenetic mechanisms linking chronic inflammation and oncogenesis.

Main Methods:

• This study is a narrative review of existing literature.
• It examines the role of environmental and genetic factors in immune dysregulation.
• It analyzes mechanisms such as inflammatory microenvironments, cytokine dysregulation, and angiogenesis.

Main Results:

• Chronic inflammation, driven by immune dysregulation, plays a key role in both IMIDs and cancer development.
• Pathogenic mechanisms include inflammatory microenvironments, altered intercellular communication, and aberrant angiogenesis.
• Immunosuppressive treatments for IMIDs can further complicate cancer risk.

Conclusions:

• There are significant gaps in the understanding of the IMIDs-cancer connection.
• Further research is essential to elucidate the intricate interplay and improve clinical management for patients.
• Investigating this relationship is critical for advancing patient care in both fields.